Columbia Asset Management’s Biogen BIIB Stock Holding History

Columbia Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-885	Closed	-$250K	–	189
2021 Q3	$250K	Sell	885 -795	-47%	-$261K	0.05%	167
2021 Q2	$582K	Buy	+1,680	New	+$509K	0.13%	110
2019 Q1	–	Sell	-335	Closed	-$101K	–	219
2018 Q4	$101K	Sell	335 -125	-27%	-$39.9K	0.03%	201
2018 Q3	$163K	Buy	+460	New	+$158K	0.04%	185
2017 Q1	–	Sell	-630	Closed	-$179K	–	173
2016 Q4	$179K	Sell	630 -365	-37%	-$108K	0.06%	176
2016 Q3	$311K	Sell	995 -210	-17%	-$62.2K	0.11%	144
2016 Q2	$291K	Buy	+1,205	New	+$318K	0.1%	141

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Columbia Asset Management's BIIB Position: Q4 2021 in Review

Columbia Asset Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 885 shares — an estimated $250K sold.

Columbia Asset Management first reported a position in BIIB in Q2 2016 and held it in 7 quarters. The position peaked at $582K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Columbia Asset Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Columbia Asset Management sold 885 Biogen shares in Q4 2021, an estimated $250K.
Columbia Asset Management first reported a position in Biogen in Q2 2016 and held it in 7 quarters.
Columbia Asset Management's Biogen position peaked at $582K in Q2 2021.
1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Columbia Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.